article thumbnail

Abstract 4139929: The mechanisms of Mid-ventricular obstruction in patients with hypertrophic cardiomyopathy: Insight from an echocardiographic study

Circulation

Background:Mid-ventricular obstruction (MVO) is a rare subtype of hypertrophic cardiomyopathy (HCM) , but it is associated with severe symptoms and worse clinical outcomes. Circulation, Volume 150, Issue Suppl_1 , Page A4139929-A4139929, November 12, 2024. Whereas the mechanisms of MVO has not fully elucidated.

article thumbnail

Gender disparities in patients undergoing extracorporeal cardiopulmonary resuscitation

Frontiers in Cardiovascular Medicine

Female patients showed a lower prevalence rate of pre-existing coronary artery disease (48% vs. 75%, p  < 0.001) and cardiomyopathy (17% vs. 34%, p  = 0.01) compared with the male patients, while the mean age and prevalence rate of other cardiovascular risk factors were balanced.

article thumbnail

Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP?HF II trial

European Journal of Heart Failure

Patients with increasing obesity have higher right- and left-sided ventricular filling pressures, increased cardiac output (CO), lower 6-min walk distance (6MWD) and worse Kansas City Cardiomyopathy Questionnaire (KCCQ) scores. of patients had BMI ≥30 kg/m 2. Strain measurements in all four chambers were maintained as BMI increased.

article thumbnail

"A patient just arrived as a transfer for NSTEMI."

Dr. Smith's ECG Blog

I quickly reviewed the patient’s records and saw that she was a 53 year old woman with a history of BMI 40, but no other identifiable risk factors for coronary artery disease. Of course, stress cardiomyopathy is a diagnosis of exclusion. Stress cardiomyopathy can be a very convincing mimic for OMI, particularly LAD OMI.

SCAD 124
article thumbnail

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure

BMI, body mass index; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide. The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status.

article thumbnail

Obesity cardiomyopathy could contribute to sudden cardiac death: a Japanese epidemiological morphological study

Cardiovascular Diabetology

Background We aimed to clarify the existence and pathological features of obesity cardiomyopathy (OCM) in Japan using our series of autopsy cases.

article thumbnail

Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER

European Journal of Heart Failure

BMI, body mass index; CI, confidence interval; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide. In addition, dapagliflozin was safe and well-tolerated, irrespective of COPD status.